The contribution of metformin to glycaemic control in patients with Type 2 diabetes mellitus receiving combination therapy with insulin

Diabetes Research and Clinical Practice

Volumn 57, Issue 2, 2002, Pages 93-98

  Tong, P C ^a   Chow, C C ^a   Jorgensen, L N ^b   Cockram, C S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b Mas Building #17 01/05 10 Shenton Way ^*  (Singapore)

Author keywords

Combination therapy; Insulin; Metformin; Type 2 diabetes

Indexed keywords

GLIBENCLAMIDE; GLICLAZIDE; GLIPIZIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; CAPILLARY BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES CONTROL; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; NIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE;

BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; FASTING; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN, ISOPHANE; MALE; METFORMIN; MIDDLE AGED; POSTPRANDIAL PERIOD; SULFONYLUREA COMPOUNDS;

EID: 0036278905     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(02)00022-0     Document Type: Article

References (20)

1. Obesity, albuminuria and hypertension among Hong Kong Chinese with non-insulin-dependent diabetes mellitus (NIDDM)
2. Metabolic evolution of type 2 diabetes: A 10 year follow up from the time of diagnosis
3. The utility of postprandial C-peptide evaluation in type 2 diabetes
4. Intensive blood-glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes
5. Is combination sulphonylurea and insulin therapy useful in NIDDM patients? A meta-analysis
6. Combination therapy in NIDDM
7. Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus
8. Comparison of morning or bedtime insulin with and without glyburide in secondary sulphonylurea failure
9. Comparison of insulin with or without continuation of oral hypoglycaemic agents in the treatment of secondary failure in NIDDM patients
10. Efficacy of insulin and sulphonylurea combination therapy in type II diabetes. A meta-analysis of the randomised placebo-controlled trials
11. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes
12. Insulin lispro in the treatment of patients with type 2 diabetes mellitus after oral agent failure
13. Comparison of bedtime NPH or preprandial regular insulin combined with glibenclamide in secondary sulphonylurea failure
14. Comparison of bedtime insulin regimes in patients with type 2 diabetes mellitus. A randomised, controlled trial
15. Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomised, double-blind, placebo-controlled trial
16. Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus
17. Efficacy of combined treatments in NIDDM patients with secondary failure of sulphonylureas. Is it predictable?
18. Adding metfromin versus insulin dose increase in insulin-treated but poorly controlled Type 2 diabetes mellitus: An open-label randomised trial
19. The effects of metformin on glycaemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control
20. Combination therapies with insulin in Type 2 Diabetes